Religare Enterprises Schedules Board Meeting & Earnings Call for Q4 & FY26 Results

2 min read     Updated on 08 May 2026, 03:45 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Religare Enterprises has announced a Board of Directors meeting on May 12, 2026, to approve Standalone and Consolidated Audited Financial Results for Q4 and FY26, followed by an earnings call on May 13, 2026, at 4:00 PM IST for management to discuss operational and financial performance. The trading window, closed since April 01, 2026, will reopen on May 14, 2026, 48 hours after the results declaration.

powered bylight_fuzz_icon
39722817

*this image is generated using AI for illustrative purposes only.

Religare Enterprises has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Tuesday, May 12, 2026, to consider and approve its audited financial results. Additionally, the company's management has scheduled an earnings call on Wednesday, May 13, 2026, to discuss the operational and financial performance for Q4 and FY26. Both intimations have been filed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The Board meeting has been convened to consider and approve the Standalone and Consolidated Audited Financial Results of the company for the Quarter and Financial Year ended March 31, 2026. The key details of the scheduled meeting are outlined below:

Parameter: Details
Meeting Date: Tuesday, May 12, 2026
Purpose: Approval of Standalone and Consolidated Audited Financial Results
Period Under Review: Quarter and Financial Year ended March 31, 2026
Regulatory Basis: Regulation 29 of SEBI (LODR) Regulations, 2015

Earnings Call Details

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the management of Religare Enterprises and its subsidiaries has scheduled an earnings call to discuss the operational and financial performance for Q4 & FY26. The details of the earnings call are as follows:

Parameter: Details
Day/Date: Wednesday, May 13, 2026
Time: 04:00 PM IST
Primary Numbers: +91 22 6280 1102 / +91 22 7115 8003
Toll Free – USA: 1 866 746 2133
Toll Free – UK: 0 808 101 1573
Toll Free – Singapore: 800 101 2045
Toll Free – Hong Kong: 800 964 448
RSVP Contact: teamreligare@adfactorspr.com

Participants are requested to pre-register for the call via the provided link. The call will be attended by the Management Team of Religare Enterprises and its subsidiaries.

Trading Window Closure

In continuation of an earlier announcement dated March 27, 2026, Religare Enterprises also informed the exchanges regarding the Trading Window Closure period applicable to dealings in the company's shares. The relevant details are as follows:

Parameter: Details
Trading Window Closure Start: April 01, 2026
Trading Window Reopens: 48 hours after declaration of financial results
Effective Reopening Date: May 14, 2026

The Trading Window was closed from April 01, 2026, and shall remain closed until 48 hours after the declaration of the aforementioned financial results, which translates to May 14, 2026. This closure is in compliance with applicable SEBI regulations governing insider trading restrictions during periods preceding the announcement of financial results.

Both intimations were signed by Anuj Jain, Company Secretary & Compliance Officer of Religare Enterprises, and were filed on May 07, 2026.

Historical Stock Returns for Religare Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
-0.23%+0.61%-0.21%-13.67%+5.29%+122.89%

How might Religare Enterprises' FY26 financial results reflect the impact of ongoing ownership disputes and corporate governance challenges on its core businesses like Care Health Insurance and Religare Broking?

Will the Q4 FY26 earnings call provide any clarity on Religare Enterprises' strategic roadmap following the prolonged battle for control between the Burman family and other stakeholders?

Could strong or weak FY26 results trigger renewed merger and acquisition interest or open market activity in Religare Enterprises shares once the trading window reopens on May 14, 2026?

Religare Enterprises Announces Leadership Transition at Material Subsidiary CHIL

2 min read     Updated on 26 Apr 2026, 10:59 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Religare Enterprises Limited has announced a complete leadership transition at its material subsidiary Care Health Insurance Limited (CHIL). Mr. Anuj Gulati's tenure as Managing Director & CEO concluded on April 25, 2026, with the Board acknowledging his instrumental role in building CHIL into the second largest standalone health insurance company. Effective April 26, 2026, Mr. Ajay Kumar Shah will assume the role of Managing Director & CEO, bringing 30 years of insurance sector experience and 14 years with CHIL, while Mr. Manish Vishnu Dodeja will serve as Executive Director with 21 years of operational expertise and 15 years at CHIL.

powered bylight_fuzz_icon
38769911

*this image is generated using AI for illustrative purposes only.

Religare Enterprises Limited has announced significant leadership changes at its material subsidiary Care Health Insurance Limited (CHIL), with both the conclusion of current leadership tenure and strategic succession planning taking shape.

Current CEO Tenure Concludes

The company has formally disclosed that the tenure of Mr. Anuj Gulati as Managing Director & CEO of CHIL has ended with effect from the close of business hours on April 25, 2026. The announcement was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parameter: Details
Outgoing CEO: Mr. Anuj Gulati (DIN: 00278955)
Reason for Change: End of Tenure
Effective Date: April 25, 2026 (close of business hours)
Regulatory Filing: SEBI Regulation 30 compliance

The Board of Directors and Management have placed on record their appreciation of Mr. Gulati's invaluable contribution during his tenure. His entrepreneurial vision and leadership acumen were instrumental in building CHIL from the ground up into a credible institution and the second largest company in the standalone health insurance segment.

Incoming Leadership Appointments

The company has secured regulatory approvals for two key executive positions to lead CHIL forward, with appointments effective April 26, 2026. The appointments received formal approval from CHIL's Board of Directors during their meeting held on November 11, 2025, following recommendations from the Nomination & Remuneration Committee.

Position: Appointee DIN Term Duration
Managing Director & CEO: Mr. Ajay Kumar Shah 11418087 Five years
Whole-time Director (Executive Director): Mr. Manish Vishnu Dodeja 11425763 Five years
Effective Date: April 26, 2026
Regulatory Approval: IRDAI approved

New Leadership Expertise

Mr. Ajay Kumar Shah brings over 30 years of extensive experience across the Insurance and Financial Services sectors to his new role as Managing Director & CEO. His association with CHIL spans 14 years, during which he has played a pivotal role in establishing the company's Services Division. Currently serving as Chief Business Officer of CHIL, Mr. Shah has successfully led the company's Business Verticals for 10 years, during which CHIL's Gross Written Premium (GWP) has grown more than thirtyfold.

Mr. Manish Vishnu Dodeja, appointed as Whole-time Director (Executive Director), brings over 21 years of experience in handling Claims, Underwriting, Product, Risk, Reinsurance, Operations, Finance, Customer Service, and Technology. He has been an integral part of CHIL for the past 15 years and currently works as Chief Operating Officer managing all Services.

Executive: Qualifications Experience
Ajay Kumar Shah: Chartered Accountant, St. Xavier's College Graduate 30+ years Insurance & Financial Services
Manish Vishnu Dodeja: Chartered Accountant, Jaihind College Graduate 21+ years across multiple insurance functions

Both appointments form part of CHIL's internal succession plan and represent strategic leadership transitions within the material subsidiary. The appointments are subject to approval from the shareholders of Religare Enterprises Limited, ensuring proper governance protocols are maintained throughout the transition process.

Historical Stock Returns for Religare Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
-0.23%+0.61%-0.21%-13.67%+5.29%+122.89%

How will the new leadership's strategy impact Care Health Insurance's market position against competitors in the standalone health insurance segment?

What are the growth targets and expansion plans under the new CEO's five-year term, given the company's previous thirtyfold GWP growth?

Will this leadership transition affect Religare Enterprises' overall financial performance and stock valuation in the coming quarters?

More News on Religare Enterprises

1 Year Returns:+5.29%